Systems and methods for treatment of hearing using dihexa
US-2024424050-A1 · Dec 26, 2024 · US
US9918912B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9918912-B2 |
| Application number | US-201615000850-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 19, 2016 |
| Priority date | Mar 11, 2008 |
| Publication date | Mar 20, 2018 |
| Grant date | Mar 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a water-in-silicone emulsion comprising a discontinuous water phase, a continuous silicone phase, and a silicone polyglucoside containing emulsifier, wherein the discontinuous water phase does not include a salt.
Opening claim text (preview).
The invention claimed is: 1. A water-in-silicone emulsion comprising a discontinuous water phase, a continuous silicone phase, and a silicone polyglucoside emulsifier, wherein the discontinuous water phase does not include a salt. 2. The water-in-silicone emulsion of claim 1 , wherein the silicone polyglucoside emulsifier includes an octyl radical and a sugar glucoside. 3. The water-in-silicone emulsion of claim 2 , wherein the sugar glucoside is a 6 carbon monosaccharide ranging from 1-8 monomers in length. 4. The water-in-silicone emulsion of claim 3 , wherein the silicone polyglucoside emulsifier has a molecular weight of at least 450 daltons. 5. The water-in-silicone emulsion of claim 1 , further comprising a co-emulsifier. 6. The water-in-silicone emulsion of claim 5 , wherein the co-emulsifier is a glucolipid. 7. The water-in-silicone emulsion of claim 6 , wherein the glucolipid includes an alkyl chain 8-20 carbons in length and a glucose portion comprising a 5 carbon monosaccharide. 8. The water-in-silicone emulsion of claim 7 , wherein the weight ratio of the silicone polyglucoside emulsifier to the glucolipid co-emulsifier is between 8:1 to 12:1. 9. The water-in-silicone emulsion of claim 1 , wherein the silicone polyglucoside emulsifier is present in an amount of between 3% to 8% by weight based on the total weight of the emulsion. 10. The water-in-silicone emulsion of claim 1 , comprising a viscosity of 20,000 to 30,000 cps at 25° C. as measured on a Brookfield Viscometer using a TC spindle at 2.5 rpm. 11. The water-in-silicone emulsion of claim 1 , wherein the continuous silicone phase comprises a cyclomethicone, an aryl silicone, a dimethicone copolyol, a cyclopentasiloxane, a dimethicone, a short chain siloxanes, or a silicone acrylate, or any combination thereof. 12. The water-in-silicone emulsion of claim 1 , wherein the emulsion is comprised in a topical skin composition. 13. The water-in-silicone emulsion of claim 1 , wherein the emulsion is comprised in a dermatologically acceptable vehicle. 14. A method of delivering a cosmetic or pharmaceutical active ingredient to skin comprising topically applying a composition comprising a cosmetic or pharmaceutical active ingredient and the water-in-silicone emulsion of claim 1 to skin, wherein topical application of the composition delivers the cosmetic or pharmaceutical active ingredient to the skin. 15. The method of claim 14 , wherein the water-in-silicone emulsion comprises a viscosity of 20,000 to 30,000 cps at 25° C. as measured on a Brookfield Viscometer using a TC spindle at 2.5 rpm. 16. The method of claim 14 , wherein the silicone polyglucoside emulsifier is present in an amount of between 3% to 8% by weight based on the total weight of water-in-silicone emulsion. 17. The method of claim 14 , wherein the silicone polyglucoside emulsifier includes an octyl radical and a sugar glucoside. 18. The method of claim 14 , wherein the continuous silicone phase of the water-in-silicone emulsion comprises a cyclomethicone, an aryl silicone, a dimethicone copolyol, a cyclopentasiloxane, a dimethicone, a short chain siloxanes, or a silicone acrylate, or any combination thereof. 19. The method of claim 14 , wherein the water-in-silicone emulsion further comprises a co-emulsifier. 20. The method of claim 19 , wherein the co-emulsifier is a glucolipid.
Drugs for dermatological disorders · CPC title
Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title
Organosilicon compounds · CPC title
Water-in-oil emulsions, e.g. Water-in-silicone emulsions · CPC title
Multiple emulsions, e.g. water-in-oil-in-water · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.